Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cannabis stocks jump as report suggests sales climbing amid COVID-19 pandemic

Stockhouse Editorial
2 Comments| March 19, 2020

{{labelSign}}  Favorites
{{errorMessage}}

Click to enlargeCannabis stocks are trading in the high green on Thursday following the announcement of a report that suggests consumers are stocking up on cannabis​ amid the COVID-19 outbreak.

Bank of America equity analyst Christopher Carey said that sales of Canadian and U.S. cannabis products are increasing over the past week, a clear sign that the pot sector may actually be adopting defensive playbook in current market conditions.

Carey also states that Aphria Inc. (TSX.APHA), with an nearly 12 percent bounce on Thursday, may see its market share in Canada rise as its peers may struggle to move product. Carey boosted Aphria's rating to a 'buy' despite lowering his price target to $5 a share.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today